CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 59 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $84,839,893 | +110.4% | 2,852,720 | +27.5% | 0.01% | +150.0% |
Q2 2023 | $40,323,985 | +13.2% | 2,237,735 | +0.9% | 0.00% | 0.0% |
Q1 2023 | $35,633,832 | -51.4% | 2,218,794 | -44.7% | 0.00% | 0.0% |
Q4 2022 | $73,375,094 | +106.6% | 4,009,568 | +121.7% | 0.00% | 0.0% |
Q3 2022 | $35,522,000 | +8.2% | 1,808,665 | +2.7% | 0.00% | 0.0% |
Q2 2022 | $32,840,000 | -12.0% | 1,760,845 | +3.5% | 0.00% | 0.0% |
Q1 2022 | $37,330,000 | +1.0% | 1,700,679 | +30.8% | 0.00% | 0.0% |
Q4 2021 | $36,944,000 | +57.3% | 1,300,374 | +16.5% | 0.00% | +100.0% |
Q3 2021 | $23,489,000 | +128.0% | 1,115,859 | +104.2% | 0.00% | 0.0% |
Q2 2021 | $10,300,000 | +42.6% | 546,432 | +15.6% | 0.00% | – |
Q1 2021 | $7,221,000 | +6.4% | 472,561 | -1.7% | 0.00% | – |
Q4 2020 | $6,784,000 | -2.4% | 480,799 | +8.3% | 0.00% | – |
Q3 2020 | $6,954,000 | -5.3% | 443,775 | +5.9% | 0.00% | -100.0% |
Q2 2020 | $7,340,000 | +122.4% | 418,975 | +86.6% | 0.00% | – |
Q1 2020 | $3,300,000 | -42.0% | 224,494 | -0.9% | 0.00% | – |
Q4 2019 | $5,685,000 | +83.2% | 226,601 | +9.8% | 0.00% | – |
Q3 2019 | $3,103,000 | -39.0% | 206,296 | +1.3% | 0.00% | – |
Q2 2019 | $5,091,000 | +112.2% | 203,628 | +93.2% | 0.00% | – |
Q1 2019 | $2,399,000 | -22.4% | 105,399 | +2.2% | 0.00% | – |
Q4 2018 | $3,093,000 | +41.3% | 103,148 | +35.0% | 0.00% | – |
Q3 2018 | $2,189,000 | – | 76,379 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 1,862,286 | $27,376,000 | 8.48% |
Vivo Capital, LLC | 3,320,801 | $48,816,000 | 4.42% |
Burrage Capital Management LLC | 282,272 | $4,022,000 | 3.96% |
Opaleye Management Inc. | 368,750 | $5,421,000 | 1.44% |
Perceptive Advisors | 2,587,953 | $38,042,000 | 0.99% |
RA Capital Management | 1,961,209 | $28,830,000 | 0.91% |
New Leaf Venture Partners, L.L.C. | 141,000 | $2,073,000 | 0.62% |
EcoR1 Capital, LLC | 350,000 | $5,145,000 | 0.54% |
Orbimed Advisors | 2,039,282 | $29,977,000 | 0.50% |
Eventide Asset Management | 947,000 | $13,921,000 | 0.45% |